Laboratorios Richmond SACIF (BA:RICH) — Market Cap & Net Worth
Market Cap & Net Worth: Laboratorios Richmond SACIF (RICH)
Laboratorios Richmond SACIF (BA:RICH) has a market capitalization of $77.81 Million (AR$107.53 Billion) as of June 22, 2026. Listed on the BA stock exchange, this Argentina-based company holds position #20254 globally and #56 in its home market, demonstrating a 1.25% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Laboratorios Richmond SACIF's stock price AR$1615.00 by its total outstanding shares 66584323 (66.58 Million). Review RICH total liabilities to assess the company's total debt and financial obligations.
Laboratorios Richmond SACIF Market Cap History: 2017 to 2026
Laboratorios Richmond SACIF's market capitalization history from 2017 to 2026. Data shows growth from $1.51 Million to $77.81 Million (59.70% CAGR).
Laboratorios Richmond SACIF Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Laboratorios Richmond SACIF's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Laboratorios Richmond SACIF's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Laboratorios Richmond SACIF's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.51 Million | $982.22 Million | $40.76 Million | 0.00x | 0.04x |
| 2018 | $1.75 Million | $1.82 Billion | -$215.60 Million | 0.00x | N/A |
| 2019 | $5.58 Million | $3.90 Billion | $116.44 Million | 0.00x | 0.05x |
| 2020 | $5.55 Million | $6.18 Billion | $486.24 Million | 0.00x | 0.01x |
| 2021 | $10.70 Million | $16.62 Billion | $591.46 Million | 0.00x | 0.02x |
| 2022 | $18.74 Million | $18.47 Billion | $163.43 Million | 0.00x | 0.11x |
| 2023 | $33.73 Million | $84.99 Billion | -$23.63 Billion | 0.00x | N/A |
| 2024 | $86.48 Million | $91.79 Billion | $23.85 Billion | 0.00x | 0.00x |
Competitor Companies of RICH by Market Capitalization
Companies near Laboratorios Richmond SACIF in the global market cap rankings as of June 22, 2026.
Key companies related to Laboratorios Richmond SACIF by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #554 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #602 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #554 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.94 |
| #602 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.20 Billion | CN¥48.42 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.50 |
Laboratorios Richmond SACIF Historical Marketcap From 2017 to 2026
Between 2017 and today, Laboratorios Richmond SACIF's market cap moved from $1.51 Million to $ 77.81 Million, with a yearly change of 59.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AR$77.81 Million | -17.18% |
| 2025 | AR$93.95 Million | +8.64% |
| 2024 | AR$86.48 Million | +156.43% |
| 2023 | AR$33.73 Million | +79.95% |
| 2022 | AR$18.74 Million | +75.23% |
| 2021 | AR$10.70 Million | +92.63% |
| 2020 | AR$5.55 Million | -0.43% |
| 2019 | AR$5.58 Million | +219.56% |
| 2018 | AR$1.75 Million | +15.73% |
| 2017 | AR$1.51 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 21st, 2026 the market cap of Laboratorios Richmond SACIF was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $77.81 Million USD |
| MoneyControl | $77.81 Million USD |
| MarketWatch | $77.81 Million USD |
| marketcap.company | $77.81 Million USD |
| Reuters | $77.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Laboratorios Richmond SACIF
Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs … Read more